Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has revolutionized treatment of aortic stenosis (AS), and both American and European guidelines have approved its use.
The global study assessed risk factors, including metabolic (such as high blood pressure, obesity and diabetes), behavioural (smoking and diet), and psychosocial (economic status and depression) in about 156,000 people without a history of CVD between the ages of 35 and 70. Living in 21 low, middle and high-income countries on five continents, they were followed for an average of 10 years.
After a rare disease caused organ failure, UC San Diego Heath transplant teams performed a heart, liver and kidney transplant on a patient. The surgery is a first for UC San Diego Health and a first in the nation to use three organs from a donor after circulatory death.
Nebraska researchers seek to identify the bioactive molecules that give chive nanoparticles their "very strong anti-inflammatory function."
Racial and ethnic minorities in Los Angeles County are more likely to live as far as or farther than five miles from a cardiac rehabilitation facility, according to a new study by investigators at the Smidt Heart Institute at Cedars-Sinai.
The latest research and expert commentary on pain management.
Researchers at the Georgia Institute of Technology and clinicians at Emory University School of Medicine are bringing a new understanding to these complicated conditions with the first high-resolution visualizations of stable spiral waves in human ventricles.
Among several lifestyle changes that may reduce cardiovascular disease, adopting the DASH (Dietary Approaches to Stop Hypertension) diet may have the greatest impact for young and middle-aged adults with stage 1 hypertension, according to new research presented at the American Heart Association’s Hypertension Scientific Sessions 2022, held Sept. 7-10, 2022, in San Diego.
Cardiac conditions in women are underdiagnosed, undertreated, and under-researched compared to men. In an important prospective study in the Canadian Journal of Cardiology, published by Elsevier, investigators report that attending a multidisciplinary dedicated women’s heart center can increase the likelihood of an accurate diagnosis and significantly improve clinical and psychological outcomes of women reporting chest pain due to insufficient heart-muscle blood flow (myocardial ischemia) but not diagnosed with obstructive coronary artery disease.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Mice lacking Regnase-1 in myeloid cells spontaneously developed severe pulmonary arterial hypertension, mirroring the same pathology in humans. The decay of mRNA by Regnase-1 leads to PAH inhibition, suggesting its possible as a disease biomarker.
A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measurable impact on vascular health.
A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published today in the American Heart Association’s flagship journal Circulation.
Having easier access to primary care physicians may increase high blood pressure awareness and control regardless of where a person lives, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, a peer-reviewed journal of the American Heart Association.
妙佑医疗国际(Mayo Clinic)参与的一项首次人体多中心试验使用了一种新型消融技术来治疗室性心动过速患者。室性心动过速是一种心律异常加快的疾病，已成为全球心源性猝死病例的主要元凶之一。
Um primeiro estudo multicêntrico em humanos envolvendo a Mayo Clinic usou uma nova técnica de ablação para pacientes com taquicardia ventricular (um ritmo cardíaco anormalmente rápido que é uma das principais causas de morte súbita cardíaca em todo o mundo).
استخدمت التجربة متعددة المراكز الأولى من نوعها على البشر والتي شملت مايو كلينك تقنية استئصال جديدة لمرضى تسرّع القلب البُطَيْني، وهو نظم قلبي سريع بشكل غير طبيعي، وسبب رئيسي للموت القلبي المفاجئ في جميع أنحاء العالم.
Un ensayo realizado por primera vez en seres humanos y en varios centros, entre los que está Mayo Clinic, empleó una nueva técnica de ablación para los pacientes con taquicardia ventricular, o ritmo cardíaco anormalmente rápido que es la causa principal de muerte cardíaca súbita en todo el mundo.
Symptoms are subjective experiences that may indicate underlying cardiovascular disease or change therein and are of fundamental significance not only to the diagnosis of cardiovascular disease (CVD) and appraisal of response to medical therapy but also directly to patients’ daily lives.
In the young population, arterial stiffness, an emerging risk factor for hypertension, indirectly raises blood pressure via an increase in insulin resistance but not via an increase in body fat, a paper published in Frontiers in Cardiovascular Medicine concludes.
A 70-year-old man is recovering safely at Ochsner Medical Center—New Orleans following a dramatic resuscitation by an Ochsner Health cardiologist that friends and family describe as “divine intervention.”
An unexplained case of severe coronary artery disease in a seemingly healthy young man led scientists at The Ohio State University Wexner Medical Center and College of Medicine to a discovery that could lead to a new way to treat high cholesterol.
Scientists working to develop new therapies and treatments for heart failure patients have discovered three proteins that can be injected immediately after a heart attack, which have the potential to preserve heart function following an attack.
The latest research on plants brought to you by Newswise.
New research from the Smidt Heart Institute at Cedars-Sinai demonstrated that women—when height is accounted for—have a 50% higher risk of developing the abnormal heart rhythm disturbance when compared to men.
Among people older than age 65 who were assessed using a short physical function test, having lower physical function was independently associated with a greater risk of developing heart attack, heart failure and stroke, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
In the Journal of Applied Physics, researchers develop a method to identify aortic valve dysfunction using complex network analysis that is accurate, simple to use, and low-cost. They used heart sound data to create a complex network of connected points, which was split into sections, and each part was represented with a node. If the sound in two portions was similar, a line was drawn between them. In a healthy heart, the graph showed two distinct clusters of points, with many nodes unconnected. A heart with aortic stenosis contained many more correlations and edges.
In Biophysics Reviews, researchers explore how human tissue models can be used to examine the impact of heart attacks and treatment of the fibrotic tissue outside the body, improving treatment and diagnosis. They use organoids, 3D organlike multicellular models derived from stem cells, to mimic natural development, structural organization, regeneration, and disease progression. Meanwhile, microfluidic devices control cell placement and fluid flow to act like the heart on a chip, while bioprinting allows cardiac tissue to be built up layer by layer.
During National Atrial Fibrillation (AFib) Awareness Month and Aortic Disease Awareness Week, Smidt Heart Institute cardiologists and surgeons are available for interviews with journalists working on stories about these common heart conditions.
A six-year analysis of more than 94,000 adults in the U.K. Biobank with no history of heart failure at enrollment has found that engaging in moderate or vigorous physical activity may lower the risk of developing heart failure, according to new research published today in the American Heart Association’s flagship journal Circulation.
A new type of extravascular implantable cardioverter-defibrillator (ICD) using a lead (thin wire) placed behind the sternum met safety and effectiveness goals for participants in a premarket global clinical study. The device effectively terminated acute and chronic life-threatening ventricular arrhythmias. The findings were presented during a late-breaking session at the European Society of Cardiology Congress and were simultaneously published in The New England Journal of Medicine.
All too often, patients go to the ER complaining of unexplained chest pain. After a battery of tests show no evidence of blocked heart arteries, the patients are sent home. Then, they return to the ER with the same symptoms. Until now. MedStar Heart & Vascular Institute is one of the few programs in the nation to have the innovative tool to find the culprit: coronary microvascular dysfunction, or CMD, a condition in which the heart’s tiniest arteries don’t dilate properly.
In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.
Mount Sinai researchers develop new risk stratification tool to optimize patient care and outcomes after TAVR
An analysis in nearly 2.3 million Europeans has found detrimental associations between cold weather and deaths from heart disease, particularly in poor neighbourhoods.
A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.
High blood pressure in pregnancy is increasing and a leading cause of maternal death
More than one in eight children (12%) receiving implanted cardiovascular defibrillators (ICDs) for heart rhythm problems exhibit signs of post-traumatic stress disorder (PTSD), according to a new report in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier.
Researchers at University Hospitals, with support from an American Heart Association® grant, will work to better understand how to successfully treat Black women diagnosed with depression who are also at risk for high blood pressure.
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program is now available for the TCT MedTech Innovation Forum. The summit will be held on the first day of TCT, the annual scientific symposium of CRF, on Friday, September 16. TCT will take place September 16-19, 2022, in Boston, Massachusetts, at the Boston Convention and Exhibition Center.
WALTHAM, Mass., Aug. 23, 2022 – Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and efficacy of the Thermedical® SERF Ablation System with the Durablate® Catheter in people with ventricular tachycardia (VT) resistant to conventional treatment.
A research study of African Americans with cardiovascular disease suggests religious practices and spirituality may contribute to heart health.
Physician-scientists assessed whether lipid concentrations and rates of lipid control changed among U.S. adults from 2007 to 2018. The researchers observed that while mean cholesterol concentrations improved among U.S. adults overall during this time period, there were concerning variations in these trends by race and ethnicity.
By estimating people’s brain age from MRI scans using machine learning, a team led by UCL researchers has identified multiple risk factors for a prematurely ageing brain.
Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.1
About 78% of respondents who said they planned to get pregnant within the next five years expressed openness to wearing the monitor on a daily basis.
Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death—an electrical malfunction in the heart that causes it to stop beating.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
